{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:59:58Z","timestamp":1790215198421,"version":"4.1.0"},"reference-count":236,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2682026ZTPY022"],"award-info":[{"award-number":["2682026ZTPY022"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2682026CX190"],"award-info":[{"award-number":["2682026CX190"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52033007"],"award-info":[{"award-number":["52033007"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52473324"],"award-info":[{"award-number":["52473324"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U22A20161"],"award-info":[{"award-number":["U22A20161"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52495011"],"award-info":[{"award-number":["52495011"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2025ZNSFSC1521"],"award-info":[{"award-number":["2025ZNSFSC1521"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2024NSFTD0002"],"award-info":[{"award-number":["2024NSFTD0002"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["GZC20261598"],"award-info":[{"award-number":["GZC20261598"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2026M793921"],"award-info":[{"award-number":["2026M793921"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFA1206500"],"award-info":[{"award-number":["2022YFA1206500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jconrel.2026.115240","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:38:27Z","timestamp":1786117107000},"page":"115240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Proximity-regulating nanotechnology for tumor treatment"],"prefix":"10.1016","volume":"398","author":[{"given":"Shijun","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunkun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaobing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.115240_bb0005","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.1039\/D2CS00943A","article-title":"Proximity-inducing modalities: the past, present, and future","volume":"52","author":"Singh","year":"2023","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2026.115240_bb0010","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1021\/acscentsci.3c00395","article-title":"Proximity-based modalities for biology and medicine","volume":"9","author":"Liu","year":"2023","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.jconrel.2026.115240_bb0015","doi-asserted-by":"crossref","first-page":"7988","DOI":"10.1038\/s41467-025-63422-1","article-title":"Mechanism and function of GPR3 regulated by a negative allosteric modulator","volume":"16","author":"Chen","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115240_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1258371","article-title":"EGFR trafficking: effect of dimerization, dynamics, and mutation","volume":"13","author":"Schultz","year":"2023","journal-title":"Front. Oncol."},{"issue":"2023","key":"10.1016\/j.jconrel.2026.115240_bb0025","article-title":"FGFR families: biological functions and therapeutic interventions in tumors","volume":"4","author":"Liu","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.jconrel.2026.115240_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2024.102826","article-title":"Targeting HER2 in solid tumors: unveiling the structure and novel epitopes","volume":"130","author":"Liu","year":"2024","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.jconrel.2026.115240_bb0035","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41422-025-01086-8","article-title":"Mimicking the TCR immune synapse for improved CAR-T cell function","volume":"35","author":"Enbar","year":"2025","journal-title":"Cell Res."},{"key":"10.1016\/j.jconrel.2026.115240_bb0040","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1038\/s41556-025-01749-z","article-title":"Membrane receptors cluster phosphatidylserine to activate LC3-associated phagocytosis","volume":"27","author":"Boada-Romero","year":"2025","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0045","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2024893118","article-title":"Cytokine receptor cluster size impacts its endocytosis and signaling","volume":"118","author":"Salavessa","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.115240_bb0050","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s41556-024-01499-4","article-title":"Clathrin-associated carriers enable recycling through a kiss-and-run mechanism","volume":"26","author":"Xu","year":"2024","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1204","article-title":"The roles of E3 ubiquitin ligases in cancer progression and targeted therapy","volume":"13","author":"Sampson","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.jconrel.2026.115240_bb0060","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/s41419-025-07957-7","article-title":"AMPK regulates ARF1 localization to membrane contact sites to facilitate fatty acid transfer between lipid droplets and mitochondria","volume":"16","author":"Chen","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2026.115240_bb0065","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s41586-024-07073-0","article-title":"UFM1 E3 ligase promotes recycling of 60S ribosomal subunits from the ER","volume":"627","author":"DaRosa","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115240_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110213","article-title":"Seipin localizes at endoplasmic-reticulum-mitochondria contact sites to control mitochondrial calcium import and metabolism in adipocytes","volume":"38","author":"Combot","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2026.115240_bb0075","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41419-022-04906-6","article-title":"Mitochondrial autophagy: molecular mechanisms and implications for cardiovascular disease","volume":"13","author":"Li","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2026.115240_bb0080","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/s41556-025-01668-z","article-title":"Endoplasmic reticulum-mitochondria contacts are prime hotspots of phospholipid peroxidation driving ferroptosis","volume":"27","author":"Sassano","year":"2025","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0085","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.cell.2023.11.040","article-title":"Making the connection: how membrane contact sites have changed our view of organelle biology","volume":"187","author":"Voeltz","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.115240_bb0090","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/s41467-025-56520-7","article-title":"Targeting ceramide transfer protein sensitizes AML to FLT3 inhibitors via a GRP78-ATF6-CHOP axis","volume":"16","author":"Sun","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115240_bb0095","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/s41581-025-00989-4","article-title":"Endoplasmic reticulum-mediated organelle crosstalk in kidney disease","volume":"21","author":"Hong","year":"2025","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0100","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1016\/j.cell.2021.03.035","article-title":"ER-to-Golgi protein delivery through an interwoven, tubular network extending from ER","volume":"184","author":"Weigel","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.115240_bb0105","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.molcel.2025.03.003","article-title":"Mitochondria-organelle crosstalk in establishing compartmentalized metabolic homeostasis","volume":"85","author":"Chen","year":"2025","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jconrel.2026.115240_bb0110","first-page":"1576","article-title":"TIGIT affects CAR NK-cell effector function in the solid tumor microenvironment by modulating immune synapse strength, Cancer","volume":"13","author":"Navin","year":"2025","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jconrel.2026.115240_bb0115","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adq8114","article-title":"Molecular dynamics at immune synapse lipid rafts influence the cytolytic behavior of CAR T cells","volume":"11","author":"Gad","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115240_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217542","article-title":"Translational study of the regulatory mechanism by which immune synapses enhance immune cell function","volume":"614","author":"Li","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2026.115240_bb0125","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41568-024-00705-7","article-title":"Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours","volume":"24","author":"Holder","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.115240_bb0130","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.115240_bb0135","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/s41590-024-02015-4","article-title":"Next-generation combination approaches for immune checkpoint therapy","volume":"25","author":"Goswami","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0140","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13045-021-01096-0","article-title":"Nanomaterials for cancer therapy: current progress and perspectives","volume":"14","author":"Cheng","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0145","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41573-025-01291-5","article-title":"In vivo chimeric antigen receptor (CAR)-T cell therapy","volume":"25","author":"Bot","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115240_bb0150","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.abm0594","article-title":"CAR T cells produced in vivo to treat cardiac injury","volume":"375","author":"Rurik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.115240_bb0155","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41577-025-01174-1","article-title":"In vivo CAR engineering for immunotherapy","volume":"25","author":"Li","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0160","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.chom.2023.03.007","article-title":"Engineered Escherichia coli for the in situ secretion of therapeutic nanobodies in the gut","volume":"31","author":"Lynch","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jconrel.2026.115240_bb0165","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1038\/s41467-022-35130-7","article-title":"Engineered Lactococcus lactis secreting Flt3L and OX40 ligand for in situ vaccination-based cancer immunotherapy","volume":"13","author":"Zhu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115240_bb0170","first-page":"939","article-title":"In situ delivery of gasdermin E mRNA promotes antitumor immunity via creatine-elicited type I interferon signaling in monocytes, Cancer","volume":"13","author":"Li","year":"2025","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jconrel.2026.115240_bb0175","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/s41573-022-00505-4","article-title":"Modulating biomolecular condensates: a novel approach to drug discovery","volume":"21","author":"Mitrea","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115240_bb0180","doi-asserted-by":"crossref","first-page":"1225704","DOI":"10.3389\/fimmu.2023.1225704","article-title":"The benefits of clustering in TNF receptor superfamily signaling","volume":"14","author":"Vanamee \u00c9","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0185","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.tibs.2022.08.002","article-title":"Ligand-independent receptor clustering modulates transmembrane signaling: a new paradigm","volume":"48","author":"S\u00e1nchez","year":"2023","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.jconrel.2026.115240_bb0190","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.2174\/0113816128283615231218094706","article-title":"Privileged scaffolds in drug discovery against human epidermal growth factor receptor 2 for cancer treatment","volume":"29","author":"Peerzada","year":"2023","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jconrel.2026.115240_bb0195","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1158\/1541-7786.MCR-24-0756","article-title":"DR5 disulfide bonding functions as a sensor and effector of protein folding stress","volume":"23","author":"Law","year":"2025","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115240_bb0200","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1038\/s41551-024-01255-x","article-title":"Engineered allogeneic T cells decoupling T-cell-receptor and CD3 signalling enhance the antitumour activity of bispecific antibodies","volume":"8","author":"Kapetanovic","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115240_bb0205","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.trecan.2023.08.005","article-title":"Stress granules and hormetic adaptation of cancer","volume":"9","author":"Redding","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.jconrel.2026.115240_bb0210","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/cas.15232","article-title":"Biomolecular condensates in cancer biology","volume":"113","author":"Suzuki","year":"2022","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jconrel.2026.115240_bb0215","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/s41581-023-00767-0","article-title":"Biomolecular condensates in kidney physiology and disease","volume":"19","author":"Gao","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceb.2023.102285","article-title":"The ubiquitous nanocluster: a molecular scale organizing principle that governs cellular information flow","volume":"86","author":"Garcia-Parajo","year":"2024","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0225","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202503543","article-title":"Clustering of membrane receptors: insights from DNA origami-based approaches","volume":"21","author":"Dom\u00ednguez","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.115240_bb0230","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.kint.2024.10.026","article-title":"TRAIL induces podocyte PANoptosis via death receptor 5 in diabetic kidney disease","volume":"107","author":"Lv","year":"2025","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2026.115240_bb0235","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1021\/acs.nanolett.4c04959","article-title":"Noncovalently bridging cell-surface proteins using synthetic peptides to modulate cell apoptosis","volume":"25","author":"Jia","year":"2025","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.115240_bb0240","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jconrel.2023.07.042","article-title":"Snoopligase-catalyzed molecular glue enables efficient generation of hyperoligomerized TRAIL variant with enhanced antitumor effect","volume":"361","author":"She","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115240_bb0245","doi-asserted-by":"crossref","first-page":"34620","DOI":"10.1021\/jacs.5c09699","article-title":"Immunoglobulin-directed phase separation for cell-specific modulation of receptor signaling","volume":"147","author":"Ren","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.115240_bb0250","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s11427-023-2490-2","article-title":"A phase separation-fortified bi-specific adaptor for conditional tumor killing","volume":"67","author":"Liu","year":"2024","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.jconrel.2026.115240_bb0255","doi-asserted-by":"crossref","first-page":"6310","DOI":"10.1021\/acs.nanolett.5c01122","article-title":"Inducing cancer cell killing using DNA nanostructure-mediated superclustering of death receptors","volume":"25","author":"Aba","year":"2025","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.115240_bb0260","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1182\/bloodadvances.2020003731","article-title":"Potent preclinical activity of hexabody-DR5\/DR5 in relapsed and\/or refractory multiple myeloma","volume":"5","author":"van der Horst","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.jconrel.2026.115240_bb0265","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.molcel.2018.02.034","article-title":"Separating actin-dependent chemokine receptor nanoclustering from dimerization indicates a role for clustering in CXCR4 signaling and function","volume":"70","author":"Mart\u00ednez-Mu\u00f1oz","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jconrel.2026.115240_bb0270","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1038\/s41467-024-47111-z","article-title":"Cell surface patching via CXCR4-targeted nanothreads for cancer metastasis inhibition","volume":"15","author":"Zhou","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115240_bb0275","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1021\/jacs.2c10428","article-title":"Cancer cell-selective membrane receptor clustering driven by VEGF secretion for in vivo therapy","volume":"145","author":"Bi","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.115240_bb0280","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.201800224","article-title":"Human serum albumin-based drug-free macromolecular therapeutics: apoptosis induction by coiled-coil-mediated cross-linking of CD20 antigens on lymphoma B cell surface","volume":"18","author":"Zhang","year":"2018","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jconrel.2026.115240_bb0285","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.202300375","article-title":"Obinutuzumab-based drug-free macromolecular therapeutics synergizes with topoisomerase inhibitors","volume":"24","author":"Gambles","year":"2024","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jconrel.2026.115240_bb0290","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/s41577-024-01061-1","article-title":"CD28 co-stimulation: novel insights and applications in cancer immunotherapy","volume":"24","author":"Lotze","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2021.101481","article-title":"The role of dendritic cells in cancer and anti-tumor immunity","volume":"52","author":"Marciscano","year":"2021","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0300","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1158\/1535-7163.MCT-24-0327","article-title":"A B7-H3-targeted CD28 bispecific antibody enhances the activity of anti-PD-1 and CD3 T-cell engager immunotherapies","volume":"24","author":"Moore","year":"2025","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jconrel.2026.115240_bb0305","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41573-022-00413-7","article-title":"Harnessing natural killer cells for cancer immunotherapy: dispatching the first responders","volume":"21","author":"Maskalenko","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115240_bb0310","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1002\/anie.201809006","article-title":"Emerging applications of nanotechnology for controlling cell-surface receptor clustering","volume":"58","author":"Zhang","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2026.115240_bb0315","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz6667","article-title":"Combination of metabolic intervention and T cell therapy enhances solid tumor immunotherapy","volume":"12","author":"Hao","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2026.115240_bb0320","article-title":"In situ self-assembly of bispecific peptide for cancer immunotherapy","volume":"61","author":"Wang","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2026.115240_bb0325","article-title":"ATP-inducible receptor oligomerization enables fine-tuning of T cell immunity","volume":"64","author":"Li","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2026.115240_bb0330","article-title":"An aptamer-functionalized DNA circuit to establish an artificial interaction between T cells and cancer cells","volume":"62","author":"Wang","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2026.115240_bb0335","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.812774","article-title":"Toll-like receptor signaling and its role in cell-mediated immunity","volume":"13","author":"Duan","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0340","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.3390\/cancers16152679","article-title":"Understanding the role of toll-like receptors 9 in breast cancer","volume":"16","author":"Al-Alem","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jconrel.2026.115240_bb0345","doi-asserted-by":"crossref","first-page":"13545","DOI":"10.1021\/jacs.5c00481","article-title":"Dynamic DNA-based nanoadjuvants for TLR9 clustering and innate immune activation in dendritic cells","volume":"147","author":"Lv","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.115240_bb0350","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41586-021-04084-z","article-title":"Structures of the HER2-HER3-NRG1\u03b2 complex reveal a dynamic dimer interface","volume":"600","author":"Diwanji","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115240_bb0355","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.lungcan.2022.11.018","article-title":"Mutant forms of EGFR promote HER2 trafficking through efficient formation of HER2-EGFR heterodimers","volume":"175","author":"Tsutsumi","year":"2023","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jconrel.2026.115240_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112612","article-title":"Trastuzumab, a monoclonal anti-HER2 antibody modulates cytotoxicity against cholangiocarcinoma via multiple mechanisms","volume":"138","author":"Panaampon","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0365","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41565-019-0626-4","article-title":"Transformable peptide nanoparticles arrest HER2 signalling and cause cancer cell death in vivo","volume":"15","author":"Zhang","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0370","article-title":"Resistance mechanisms and prospects of trastuzumab","volume":"14","author":"Wang","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0375","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1186\/s12967-024-05445-8","article-title":"HER3 receptor and its role in the therapeutic management of metastatic breast cancer","volume":"22","author":"Zhu","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jconrel.2026.115240_bb0380","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1038\/s41467-019-09683-z","article-title":"CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-\u03b1 production in systemic sclerosis","volume":"10","author":"Lande","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115240_bb0385","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/s41565-024-01759-2","article-title":"Synthetic polypeptides inhibit nucleic acid-induced inflammation in autoimmune diseases by disrupting multivalent TLR9 binding to LL37-DNA bundles","volume":"19","author":"Liu","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2021.100796","article-title":"Anticancer drug resistance: an update and perspective","volume":"59","author":"Nussinov","year":"2021","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.jconrel.2026.115240_bb0395","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/febs.17023","article-title":"Microbial amyloids in neurodegenerative amyloid diseases","volume":"292","author":"Sampson","year":"2025","journal-title":"FEBS J."},{"key":"10.1016\/j.jconrel.2026.115240_bb0400","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1021\/acsnano.3c00001","article-title":"Graphene quantum dots modulate stress granule assembly and prevent abnormal phase transition of fused in sarcoma protein","volume":"17","author":"Zhang","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115240_bb0405","doi-asserted-by":"crossref","first-page":"28669","DOI":"10.1021\/jacs.4c03420","article-title":"Homologous peptide foldamer promotes FUS aggregation and triggers cancer cell death","volume":"146","author":"Wang","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.115240_bb0410","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.3390\/ijms24054741","article-title":"DNA damage and its role in cancer therapeutics","volume":"24","author":"Moon","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115240_bb0415","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41392-021-00648-7","article-title":"DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115240_bb0420","doi-asserted-by":"crossref","first-page":"24426","DOI":"10.1021\/acsnano.4c07514","article-title":"Near-infrared laser-switching DNA phase separation nanoinducer for glioma therapy","volume":"18","author":"Chen","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115240_bb0425","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201606","article-title":"Lipid metabolism and cancer","volume":"218","author":"Bian","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2026.115240_bb0430","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.tips.2024.04.007","article-title":"Emerging targets in lipid metabolism for cancer therapy","volume":"45","author":"Terry","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2026.115240_bb0435","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13045-023-01498-2","article-title":"Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics","volume":"16","author":"Jin","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0440","article-title":"Ruthenium(II) lipid-mimics drive lipid phase separation to arouse autophagy-ferroptosis cascade for photoimmunotherapy","volume":"12","author":"Zheng","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.115240_bb0445","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202301663","article-title":"Mechanistic understanding of protein corona formation around nanoparticles: old puzzles and new insights","volume":"19","author":"Nienhaus","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.115240_bb0450","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1039\/D3CC05834D","article-title":"Targeting misfolding and aggregation of the amyloid-\u03b2 peptide and mutant p53 protein using multifunctional molecules","volume":"60","author":"Grcic","year":"2024","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jconrel.2026.115240_bb0455","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1021\/acsnano.4c08293","article-title":"Tuning surface valences of nanoengagers to enhance their structural advantages for efficiently redirecting T cells against solid tumors","volume":"19","author":"Huang","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115240_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2026.115874","article-title":"Bifunctional proximity-inducing strategies for targeted and programmable post-translational modifications","volume":"234","author":"Tanga","year":"2026","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115240_bb0465","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41580-024-00729-9","article-title":"Targeted protein degradation: from mechanisms to clinic","volume":"25","author":"Tsai","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115765","article-title":"Targeted protein modification as a paradigm shift in drug discovery","volume":"260","author":"Amirian","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jconrel.2026.115240_bb0475","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"B\u00e9k\u00e9s","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115240_bb0480","doi-asserted-by":"crossref","first-page":"7575","DOI":"10.1038\/s41467-025-62776-w","article-title":"Targeted degradation of cell surface proteins through endocytosis triggered by cell-penetrating peptide-small molecule conjugates","volume":"16","author":"He","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115240_bb0485","first-page":"120","article-title":"Manipulating autophagic degradation in human diseases: from mechanisms to interventions","volume":"1","author":"Zhang","year":"2022","journal-title":"Lifestyle Med."},{"key":"10.1016\/j.jconrel.2026.115240_bb0490","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/procel\/pwaf069","article-title":"Structure-based engineering of the midnolin-proteasome pathway for targeted protein degradation","volume":"17","author":"Wang","year":"2026","journal-title":"Protein Cell"},{"key":"10.1016\/j.jconrel.2026.115240_bb0495","doi-asserted-by":"crossref","first-page":"25645","DOI":"10.1021\/acsnano.5c00985","article-title":"Lysosome-targeting nanochimeras attenuating liver fibrosis by interconnected transforming growth factor-\u03b2 reduction and activin receptor-like kinase 5 degradation","volume":"19","author":"Liu","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115240_bb0500","article-title":"Nano-LYTACs for degradation of membrane proteins and inhibition of CD24\/Siglec-10 signaling pathway","volume":"10","author":"Wang","year":"2023","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.jconrel.2026.115240_bb0505","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/s41589-021-00770-1","article-title":"LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation","volume":"17","author":"Ahn","year":"2021","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0510","doi-asserted-by":"crossref","first-page":"40751","DOI":"10.1021\/jacs.5c13695","article-title":"Development of dual-receptor lysosome-targeting chimeras for protein degradation","volume":"147","author":"Wang","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.115240_bb0515","doi-asserted-by":"crossref","first-page":"8731","DOI":"10.1038\/s41467-024-52975-2","article-title":"CYpHER: catalytic extracellular targeted protein degradation with high potency and durable effect","volume":"15","author":"Crook","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115240_bb0520","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1038\/s41467-024-46130-0","article-title":"A co-assembly platform engaging macrophage scavenger receptor a for lysosome-targeting protein degradation","volume":"15","author":"Wang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115240_bb0525","doi-asserted-by":"crossref","first-page":"25490","DOI":"10.1021\/jacs.4c04794","article-title":"Development of integrin-facilitated bispecific aptamer chimeras for membrane protein degradation","volume":"146","author":"Sun","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.115240_bb0530","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41586-024-07948-2","article-title":"Designed endocytosis-inducing proteins degrade targets and amplify signals","volume":"638","author":"Huang","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115240_bb0535","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1038\/s41589-025-01924-1","article-title":"Polyvalent folate receptor-targeting chimeras for degradation of membrane proteins","volume":"21","author":"Xiao","year":"2025","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0540","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41586-024-07947-3","article-title":"Transferrin receptor targeting chimeras for membrane protein degradation","volume":"638","author":"Zhang","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115240_bb0545","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202507608","article-title":"Engineered virus-like nanoparticles enable multimodal protein degradation for enhanced tumor therapy","volume":"37","author":"Dou","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115240_bb0550","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202501222","article-title":"Sortilin-mediated rapid, precise and sustained degradation of membrane proteins via mRNA-encoded lysosome-targeting chimera","volume":"12","author":"Chang","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.115240_bb0555","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1021\/acs.bioconjchem.4c00512","article-title":"Lysosome-targeting chimera using mannose-6-phosphate glycans derived from glyco-engineered yeast","volume":"36","author":"Kim","year":"2025","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2026.115240_bb0560","article-title":"A self-assembling LYTAC mediates CTGF degradation and remodels inflammatory tumor microenvironment for triple-negative breast cancer therapy","volume":"12","author":"Lin","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.jconrel.2026.115240_bb0565","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/s41467-025-56648-6","article-title":"A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy","volume":"16","author":"Xiao","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115240_bb0570","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.chembiol.2026.01.008","article-title":"Lysosome-targeting chimeras enable targeted protein degradation","volume":"33","author":"Li","year":"2026","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0575","doi-asserted-by":"crossref","DOI":"10.1126\/science.adf6249","article-title":"Elucidating the cellular determinants of targeted membrane protein degradation by lysosome-targeting chimeras","volume":"382","author":"Ahn","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.115240_bb0580","doi-asserted-by":"crossref","first-page":"18040","DOI":"10.1021\/acs.jmedchem.5c01019","article-title":"Small-molecule ligands targeting lysosome-shuttling receptors and the emerging landscape of lysosome-targeting chimeras","volume":"68","author":"Yang","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2026.115240_bb0585","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202417942","article-title":"A bifunctional lysosome-targeting chimera nanoplatform for tumor-selective protein degradation and enhanced cancer immunotherapy","volume":"37","author":"Xing","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115240_bb0590","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/s41467-022-28520-4","article-title":"The AUTOTAC chemical biology platform for targeted protein degradation via the autophagy-lysosome system","volume":"13","author":"Ji","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115240_bb0595","doi-asserted-by":"crossref","DOI":"10.4028\/b-wjQRP6","article-title":"Supramolecular artificial Nano-AUTACs enable tumor-specific metabolism protein degradation for synergistic immunotherapy","volume":"10","author":"Wang","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115240_bb0600","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3390\/pharmaceutics15010195","article-title":"A mechanistic pharmacodynamic modeling framework for the assessment and optimization of proteolysis targeting chimeras (PROTACs)","volume":"15","author":"Haid","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115240_bb0605","first-page":"24785","article-title":"ATNC: versatile nanobody chimeras for autophagic degradation of intracellular unligandable and undruggable proteins","volume":"145","author":"He","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.115240_bb0610","article-title":"Engineering covalent aptamer chimeras for enhanced autophagic degradation of membrane proteins","volume":"64","author":"Shi","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2026.115240_bb0615","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41587-025-02659-z","article-title":"A tissue-specific atlas of protein-protein associations enables prioritization of candidate disease genes","volume":"44","author":"Laman Trip","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0620","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/s41589-024-01803-1","article-title":"Chemically engineered antibodies for autophagy-based receptor degradation","volume":"21","author":"Cheng","year":"2025","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0625","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/d41573-024-00187-0","article-title":"The targeted protein degradation landscape","volume":"24","author":"Farley","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115240_bb0630","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/s41392-024-02004-x","article-title":"Targeted protein degradation: advances in drug discovery and clinical practice","volume":"9","author":"Zhong","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115240_bb0635","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202501857","article-title":"Membrane-bounded intracellular E3 ubiquitin ligase-targeting chimeras (MembTACs) for targeted membrane protein degradation","volume":"64","author":"Mo","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2026.115240_bb0640","doi-asserted-by":"crossref","first-page":"10382","DOI":"10.1038\/s41467-024-54854-2","article-title":"MMP-2-triggered, mitochondria-targeted PROTAC-PDT therapy of breast cancer and brain metastases inhibition","volume":"15","author":"Tong","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115240_bb0645","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1038\/s41587-024-02494-8","article-title":"Engineered platelets as targeted protein degraders and application to breast cancer models","volume":"43","author":"Chen","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0650","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1021\/acs.jmedchem.5c03024","article-title":"Unhooking the hook: optimization of the aurora a targeting PROTAC JB170 to CCT400028, an in vitro degrader chemical probe","volume":"69","author":"O\u2019Hanlon","year":"2026","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2026.115240_bb0655","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1038\/s41591-023-02635-7","article-title":"IRAK4 degrader in hidradenitis suppurativa and atopic dermatitis: a phase 1 trial","volume":"29","author":"Ackerman","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2026.115240_bb0660","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1158\/0008-5472.CAN-25-1301","article-title":"CFT1946 is an orally available brain-penetrant BRAFV600-mutant degrader that overcomes BRAF inhibitor resistance","volume":"86","author":"Kreger","year":"2026","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115240_bb0665","article-title":"Advances in post-translational modifications of proteins and cancer immunotherapy","volume":"14","author":"Li","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0670","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12943-025-02397-5","article-title":"Post-translational modifications of cancer immune checkpoints: mechanisms and therapeutic strategies","volume":"24","author":"Jia","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2026.115240_bb0675","doi-asserted-by":"crossref","first-page":"16700","DOI":"10.1021\/jacs.1c07850","article-title":"Targeted protein acetylation in cells using heterobifunctional molecules","volume":"143","author":"Wang","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.115240_bb0680","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1021\/jacs.2c11706","article-title":"Targeted dephosphorylation of tau by phosphorylation targeting chimeras (PhosTACs) as a therapeutic modality","volume":"145","author":"Hu","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.115240_bb0685","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/s41586-020-2851-2","article-title":"Immune receptor inhibition through enforced phosphatase recruitment","volume":"586","author":"Fernandes","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115240_bb0690","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1021\/acssynbio.2c00337","article-title":"Induced CD45 proximity potentiates natural killer cell receptor antagonism","volume":"11","author":"Ren","year":"2022","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0695","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/s41589-020-0622-x","article-title":"Targeted glycan degradation potentiates the anticancer immune response in vivo","volume":"16","author":"Gray","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0700","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cell.2022.12.016","article-title":"Dual-specificity RNA aptamers enable manipulation of target-specific O-GlcNAcylation and unveil functions of O-GlcNAc on \u03b2-catenin","volume":"186","author":"Zhu","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.115240_bb0705","doi-asserted-by":"crossref","first-page":"22445","DOI":"10.1021\/jacs.4c05665","article-title":"Aptamer-based enforced phosphatase-recruiting chimeras inhibit receptor tyrosine kinase signal transduction","volume":"146","author":"Wu","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.115240_bb0710","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1038\/s41589-024-01741-y","article-title":"Methylarginine targeting chimeras for lysosomal degradation of intracellular proteins","volume":"20","author":"Seabrook","year":"2024","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0715","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.tips.2026.02.010","article-title":"Induced proximity for dephosphorylation","volume":"47","author":"Park","year":"2026","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2026.115240_bb0720","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.chembiol.2025.12.012","article-title":"Deciphering phosphorylation TACtics: advances in phosphorylation targeting strategies and bifunctional modalities","volume":"33","author":"Ke","year":"2026","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0725","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","article-title":"DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer","volume":"593","author":"Mao","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115240_bb0730","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/s41568-025-00836-5","article-title":"Endoplasmic reticulum stress responses in anticancer immunity","volume":"25","author":"Hwang","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.115240_bb0735","article-title":"Lipid droplet-organized MDM2-mediated P53 degradation: a metabolic switch governing diet-driven tumor progression","volume":"12","author":"Liu","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.jconrel.2026.115240_bb0740","article-title":"Phase separation of RXR\u03b3 drives tumor chemoresistance and represents a therapeutic target for small-cell lung cancer","volume":"122","author":"Wang","year":"2025","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2026.115240_bb0745","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41586-023-06255-6","article-title":"Phase separation of FSP1 promotes ferroptosis","volume":"619","author":"Nakamura","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115240_bb0750","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.molcel.2025.03.009","article-title":"Hypoxia-induced phase separation of ZHX2 alters chromatin looping to drive cancer metastasis","volume":"85","author":"Gao","year":"2025","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jconrel.2026.115240_bb0755","first-page":"1223","article-title":"RIOK1 phase separation restricts PTEN translation via stress granules activating tumor growth in hepatocellular carcinoma","volume":"6","author":"Meng","year":"2025","journal-title":"Nat. Can."},{"key":"10.1016\/j.jconrel.2026.115240_bb0760","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.3390\/ijms22031013","article-title":"Cargo recognition and function of selective autophagy receptors in plants","volume":"22","author":"Luo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115240_bb0765","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/s41422-021-00532-7","article-title":"Degradation of lipid droplets by chimeric autophagy-tethering compounds","volume":"31","author":"Fu","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.jconrel.2026.115240_bb0770","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41565-025-01909-0","article-title":"Nanoinducer-mediated mitochondria-selective degradation enhances T cell immunotherapy against multiple cancers","volume":"20","author":"Pan","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0775","doi-asserted-by":"crossref","first-page":"23939","DOI":"10.1021\/jacs.3c05199","article-title":"Autophagy receptor-inspired antibody-fusion proteins for targeted intracellular degradation","volume":"145","author":"Jiang","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.115240_bb0780","doi-asserted-by":"crossref","first-page":"36478","DOI":"10.1021\/acsnano.5c10801","article-title":"Modular nanoassemblies mimicking p62 aggregates for targeted organelle sequestration and degradation against breast cancer","volume":"19","author":"Li","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115240_bb0785","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/s41590-024-01896-9","article-title":"T cell dysfunction and therapeutic intervention in cancer","volume":"25","author":"Zebley","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0790","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/s41467-019-09263-1","article-title":"ER stress-induced mediator C\/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression","volume":"10","author":"Cao","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115240_bb0795","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41586-025-09539-1","article-title":"Proteotoxic stress response drives T cell exhaustion and immune evasion","volume":"647","author":"Wang","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115240_bb0800","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.trecan.2022.06.006","article-title":"Decoding endoplasmic reticulum stress signals in cancer cells and antitumor immunity","volume":"8","author":"Salvagno","year":"2022","journal-title":"Trends Cancer"},{"key":"10.1016\/j.jconrel.2026.115240_bb0805","article-title":"Mitochondrial dynamics and metabolic attributes regulate function of natural killer cell and infiltration in tumor microenvironment modulating disease progression","volume":"1880","author":"Ghosh","year":"2025","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2026.115240_bb0810","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1038\/s41467-026-69546-2","article-title":"Deficiency of lysosomal TMEM175 in myeloid macrophages exerts anti-tumor immunity via inflammasome and cross-presentation pathway","volume":"17","author":"Zhang","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115240_bb0815","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41392-024-01839-8","article-title":"Mitochondrial dysfunction: mechanisms and advances in therapy","volume":"9","author":"Zong","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115240_bb0820","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2026.115081","article-title":"Targeted degradation of intracellular organelles: strategies and implications","volume":"396","author":"Lu","year":"2026","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115240_bb0825","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41392-025-02332-6","article-title":"Immunological synapse: structures, molecular mechanisms and therapeutic implications in disease","volume":"10","author":"Chao","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115240_bb0830","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.ccell.2024.09.010","article-title":"The hallmarks of cancer immune evasion","volume":"42","author":"Galassi","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2026.115240_bb0835","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41577-023-00982-7","article-title":"New immune cell engagers for cancer immunotherapy","volume":"24","author":"Fenis","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0840","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41577-022-00707-2","article-title":"A guide to antigen processing and presentation","volume":"22","author":"Pishesha","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0845","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40364-021-00294-9","article-title":"The landscape of bispecific T cell engager in cancer treatment","volume":"9","author":"Zhou","year":"2021","journal-title":"Biomark. Res."},{"key":"10.1016\/j.jconrel.2026.115240_bb0850","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1053\/j.gastro.2021.10.037","article-title":"Efficacy of biologic drugs in short-duration versus long-duration inflammatory bowel disease: a systematic review and an individual-patient data meta-analysis of randomized controlled trials","volume":"162","author":"Ben-Horin","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2026.115240_bb0855","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1007\/s00415-023-11617-1","article-title":"Ravulizumab pharmacokinetics and pharmacodynamics in patients with generalized myasthenia gravis","volume":"270","author":"Vu","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0860","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202503060","article-title":"Modular design of T cell nanoengagers for tumor immunotherapy via genetically engineered lipid-tagged antibody fragments","volume":"37","author":"Kang","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115240_bb0865","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113869","article-title":"A TCR nanovesicle antibody for redirecting T cells and reversing immunosuppression as a tumor immunotherapy strategy","volume":"384","author":"Li","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115240_bb0870","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1186\/s12951-024-02781-1","article-title":"A nanobody-guided multifunctional T cell engager promotes strong anti-tumor responses via synergistic immuno-photothermal effects","volume":"22","author":"Xie","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0875","article-title":"Bi-functional topospecific nanoparticles to promote immune-tumor cell engagement as a new immunotherapeutic strategy","volume":"38","author":"Ortu\u00f1o-Bernal","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115240_bb0880","doi-asserted-by":"crossref","first-page":"6866","DOI":"10.1021\/acs.nanolett.2c00582","article-title":"Programmable bispecific nano-immunoengager that captures T cells and reprograms tumor microenvironment","volume":"22","author":"Zhang","year":"2022","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.115240_bb0885","first-page":"485","article-title":"Precision-activated T-cell engagers targeting HER2 or EGFR and CD3 mitigate on-target, off-tumor toxicity for immunotherapy in solid tumors","volume":"4","author":"Cattaruzza","year":"2023","journal-title":"Nat. Can."},{"key":"10.1016\/j.jconrel.2026.115240_bb0890","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41551-024-01202-w","article-title":"Targeted desialylation and cytolysis of tumour cells by fusing a sialidase to a bispecific T-cell engager","volume":"8","author":"Yang","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115240_bb0895","article-title":"1314 first-in-human evaluation of HF50, a novel liposomal HER2\u00d7CD3 T cell engager with TLR agonist payload, demonstrates tolerability and early clinical response","volume":"13","author":"Liu","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2026.115240_bb0900","doi-asserted-by":"crossref","first-page":"11111","DOI":"10.1038\/s41467-025-66087-y","article-title":"Organ-specific delivery of an mRNA-encoded bispecific T cell engager targeting glypican-3 in hepatocellular carcinoma","volume":"16","author":"Huang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115240_bb0905","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1158\/1078-0432.CCR-24-2247","article-title":"Clinical pharmacology of cytokine release syndrome with T-cell engaging bispecific antibodies: current insights and drug development strategies","volume":"31","author":"Radtke","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115240_bb0910","doi-asserted-by":"crossref","DOI":"10.1111\/cts.70384","article-title":"Predicting the pharmacokinetics of T-cell engagers as a function of target-mediated drug disposition","volume":"18","author":"Penney","year":"2025","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.jconrel.2026.115240_bb0915","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ccell.2026.03.011","article-title":"Unlocking the potential of T cell engagers in solid tumors","volume":"44","author":"Wingrove","year":"2026","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2026.115240_bb0920","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/s41565-025-02008-w","article-title":"Nanotechnology for CAR T cells and tumour-infiltrating lymphocyte therapies","volume":"20","author":"Lafuente-G\u00f3mez","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0925","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41571-020-0426-7","article-title":"Exploring the NK cell platform for cancer immunotherapy","volume":"18","author":"Myers","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0930","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41586-023-06945-1","article-title":"Natural killer cell therapies","volume":"626","author":"Vivier","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115240_bb0935","doi-asserted-by":"crossref","DOI":"10.1093\/jleuko\/qiaf107","article-title":"An IL-15-modified NKp30\u00d7HER2 trispecific NK cell engager enhances NK cell activation and tumor cell killing","volume":"117","author":"Cheng","year":"2025","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0940","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41571-024-00905-y","article-title":"Bispecific and multispecific antibodies in oncology: opportunities and challenges","volume":"21","author":"Goebeler","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0945","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/s41551-025-01425-5","article-title":"Engineering multi-specific nano-antibodies for cancer immunotherapy","volume":"9","author":"Fan","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115240_bb0950","doi-asserted-by":"crossref","first-page":"6211","DOI":"10.1038\/s41467-024-50474-y","article-title":"Orchestrating NK and T cells via tri-specific nano-antibodies for synergistic antitumor immunity","volume":"15","author":"Ye","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115240_bb0955","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.102075","article-title":"Protein cage nanoparticle-based NK cell-engaging nanodrones (NKeNDs) effectively recruit NK cells to target tumor sites and suppress tumor growth","volume":"54","author":"Park","year":"2024","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2026.115240_bb0960","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/s41565-024-01736-9","article-title":"A bispecific nanosystem activates endogenous natural killer cells in the bone marrow for haematologic malignancies therapy","volume":"19","author":"Zhang","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115240_bb0965","article-title":"A transformable supramolecular bispecific cell engager for augmenting natural killer and T cell-based cancer immunotherapy","volume":"36","author":"Chen","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115240_bb0970","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41551-025-01450-4","article-title":"Bispecific killer cell engager-secreting CAR-T cells redirect natural killer specificity to enhance antitumour responses","volume":"10","author":"Fan","year":"2026","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115240_bb0975","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","article-title":"Macrophages as tools and targets in cancer therapy","volume":"21","author":"Mantovani","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115240_bb0980","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s41551-025-01483-9","article-title":"Phagocytic clearance of targeted cells with a synthetic ligand","volume":"10","author":"Yamato","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115240_bb0985","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41573-022-00470-y","article-title":"Drugging the efferocytosis process: concepts and opportunities","volume":"21","author":"Mehrotra","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115240_bb0990","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1158\/2326-6066.CIR-21-0553","article-title":"A multispecific anti-CD40 DARPin construct induces tumor-selective CD40 activation and tumor regression","volume":"10","author":"Rigamonti","year":"2022","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.jconrel.2026.115240_bb0995","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.150068","article-title":"Bi-specific nanoparticle-based engager capable of in situ activation of anti-tumor immune responses for postoperative cancer immunotherapy","volume":"485","author":"Hao","year":"2024","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.jconrel.2026.115240_bb1000","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101313","article-title":"Bi-specific macrophage nano-engager for cancer immunotherapy","volume":"41","author":"Zhao","year":"2021","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2026.115240_bb1005","doi-asserted-by":"crossref","first-page":"30332","DOI":"10.1021\/acsnano.4c07364","article-title":"Engineered outer membrane vesicles as nanosized immune cell engagers for enhanced solid tumor immunotherapy","volume":"18","author":"Sun","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115240_bb1010","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202410340","article-title":"Engineered nanoparticles for enhanced antitumoral synergy between macrophages and T cells in the tumor microenvironment","volume":"36","author":"Moon","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115240_bb1015","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41568-024-00787-3","article-title":"Dendritic cell maturation in cancer","volume":"25","author":"Moon","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.115240_bb1020","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/s41551-021-00800-2","article-title":"Rejuvenation of tumour-specific T cells through bispecific antibodies targeting PD-L1 on dendritic cells","volume":"5","author":"Liu","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115240_bb1025","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41392-024-01838-9","article-title":"Targeting BCL9\/BCL9L enhances antigen presentation by promoting conventional type 1 dendritic cell (cDC1) activation and tumor infiltration","volume":"9","author":"He","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115240_bb1030","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cell.2023.12.011","article-title":"Bispecific dendritic-T cell engager potentiates anti-tumor immunity","volume":"187","author":"Shapir Itai","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.115240_bb1035","doi-asserted-by":"crossref","DOI":"10.1126\/science.abe9124","article-title":"Canonical T cell receptor docking on peptide-MHC is essential for T cell signaling","volume":"372","author":"Zareie","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.115240_bb1040","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41565-023-01333-2","article-title":"Membrane-anchored DNA nanojunctions enable closer antigen-presenting cell\u2013T-cell contact in elevated T-cell receptor triggering","volume":"18","author":"Du","year":"2023","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115240_bb1045","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12916-021-02006-4","article-title":"Perspectives of tumor-infiltrating lymphocyte treatment in solid tumors","volume":"19","author":"Wang","year":"2021","journal-title":"BMC Med."},{"key":"10.1016\/j.jconrel.2026.115240_bb1050","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41392-025-02325-5","article-title":"Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments","volume":"10","author":"Xu","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115240_bb1055","doi-asserted-by":"crossref","first-page":"9800","DOI":"10.1021\/jacs.4c18455","article-title":"Enhancing T-cell infiltration and immunity in solid tumors via DNA nanolinker-mediated monocyte hitchhiking","volume":"147","author":"Wen","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.115240_bb1060","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1380142","article-title":"CD89-mediated recruitment of macrophages via a bispecific antibody enhances anti-tumor efficacy","volume":"7","author":"Li","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jconrel.2026.115240_bb1065","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41573-025-01316-z","article-title":"Induced proximity-based therapeutic modalities","volume":"25","author":"King","year":"2026","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115240_bb1070","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/s41587-025-02592-1","article-title":"Induced proximity at the cell surface","volume":"43","author":"Till","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115240_bb1075","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/molecules31010033","article-title":"An update on clinically advanced PROTAC degraders and their synthesis","volume":"31","author":"Acharyya","year":"2026","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2026.115240_bb1080","doi-asserted-by":"crossref","first-page":"10503","DOI":"10.1021\/acs.jmedchem.5c01250","article-title":"RIPTACs for precision cancer therapy: a novel modality with the inspiration of HLD-0915 as the first candidate in clinical trials","volume":"68","author":"Ma","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2026.115240_bb1085","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1704814","article-title":"How do nanoparticle properties shape pharmacokinetics and pharmacodynamics? A mechanistic review","volume":"16","author":"Peralta-Cuevas","year":"2026","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115240_bb1090","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2174\/1389201022666210714145356","article-title":"Cellular uptake pathways of nanoparticles: process of endocytosis and factors affecting their fate","volume":"23","author":"Varma","year":"2022","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115240_bb1095","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2026.115880","article-title":"Nanotechnology enabled proximity-induced protein degradation from multiscale bottlenecks to precision therapeutics","volume":"234","author":"Pan","year":"2026","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115240_bb1100","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114635","article-title":"Protein corona: friend or foe? Co-opting serum proteins for nanoparticle delivery","volume":"192","author":"Kim","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115240_bb1105","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2026.103101","article-title":"From nanoparticle-protein to nanoparticle-complement interactions","volume":"70","author":"Moghimi","year":"2026","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2026.115240_bb1110","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102163","article-title":"Anti-PEG antibodies: current situation and countermeasures","volume":"55","author":"Fu","year":"2024","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2026.115240_bb1115","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2026.119385","article-title":"Inflammatory and immune-mediated toxicity of lipid nanoparticles","volume":"199","author":"Kim","year":"2026","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2026.115240_bb1120","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jconrel.2022.12.049","article-title":"Orthogonal and complementary measurements of properties of drug products containing nanomaterials","volume":"354","author":"Simon","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115240_bb1125","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/s41565-023-01371-w","article-title":"Active ingredient vs excipient debate for nanomedicines","volume":"18","author":"Hemmrich","year":"2023","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115240_bb1130","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/s41589-022-01192-3","article-title":"Programming cell-surface signaling by phase-separation-controlled compartmentalization","volume":"18","author":"Li","year":"2022","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jconrel.2026.115240_bb1135","article-title":"TRPM8 regulates mitochondrial ca 2+ \u2212dynamics, temperature and endoplasmic reticulum-mitochondrial contact points in T cell","volume":"30","author":"Chang","year":"2026","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.jconrel.2026.115240_bb1140","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1007\/s00044-025-03454-w","article-title":"Nano-TPD: using nanoparticle-based systems to improve the delivery and therapeutic effect of targeted protein degraders","volume":"34","author":"Dey","year":"2025","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.jconrel.2026.115240_bb1145","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.68311","article-title":"Tight nanoscale clustering of Fc\u03b3 receptors using DNA origami promotes phagocytosis","volume":"10","author":"Kern","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.jconrel.2026.115240_bb1150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116457","article-title":"Multivalent CXCR4-targeting nanobody formats differently affect affinity, receptor clustering, and antagonism","volume":"227","author":"Anbuhl","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115240_bb1155","doi-asserted-by":"crossref","first-page":"21398","DOI":"10.1039\/D4NR02408G","article-title":"Shape-dependent cellular uptake of iron oxide nanorods: mechanisms of endocytosis and implications on cell labeling and cellular delivery","volume":"16","author":"Thamizhchelvan","year":"2024","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2026.115240_bb1160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114447","article-title":"Pre-programming the protein corona: from avoidance to endogenous targeting","volume":"389","author":"Kumari","year":"2026","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115240_bb1165","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1038\/s41401-025-01538-2","article-title":"Targeting neurodegenerative disease-associated protein aggregation with proximity-inducing modalities","volume":"46","author":"Ge","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jconrel.2026.115240_bb1170","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s13760-025-02905-w","article-title":"The therapeutic efficacy of nanoparticles in the treatment of alzheimer\u2019s disease","volume":"126","author":"Ntondini","year":"2026","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.jconrel.2026.115240_bb1175","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1038\/s41467-026-70898-y","article-title":"DC-CD4 bispecific tolerogenic nanovesicles induce antigen-specific regulatory T cells and ameliorate collagen-induced arthritis in mice","volume":"17","author":"Zhao","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115240_bb1180","doi-asserted-by":"crossref","DOI":"10.1016\/j.onano.2026.100296","article-title":"Multi-stimuli responsive nanoparticles: next-generation platforms for smart drug delivery","volume":"29","author":"Ahmad","year":"2026","journal-title":"OpenNano"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926006449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926006449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:02:44Z","timestamp":1790211764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926006449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":236,"alternative-id":["S0168365926006449"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115240","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proximity-regulating nanotechnology for tumor treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115240","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115240"}}